Return
EU’s fragmented early-stage medical device study requirements need reform
M
J
A
J
T
S
F
DOI:10.1038/s41551-026-01750-3.png)
Abstract
En 中文
Legislative change must fix the European Union’s disharmonized map of early-stage medical device clinical study requirements, whereby fragmented interpretations across Member States create barriers to innovation and delay patient access to life-saving technologies.
Journal
IF:
26.6
Papers:
1.7K
Citations:
2.0W
